What is the role of Rhesus (Rh) typing in recipient organ/hematopoietic stem cell testing?

Updated: Aug 01, 2018
  • Author: Victoria K Gonsorcik, DO; Chief Editor: Jun Teruya, MD, DSc, FCAP  more...
  • Print
Answer

Answer

The recipient has a type and screen performed to assess Rh compatibility between the recipient and potential organ donors. Hematopoietic stem cell testing is the only instance when Rh type does not have to be identical. Donor hematopoietic progenitor stem cells will engraft into the recipient's chemotherapy-induced "empty" or "wiped out" marrow and replace the recipient's blood ABO type and Rh type if the engraftment is successful.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!